Zacks: Oculus Innovative Sciences Inc. (NASDAQ:OCLS) Given Average Recommendation of “Strong Buy” by Analysts

Shares of Oculus Innovative Sciences Inc. (NASDAQ:OCLS) have been assigned a consensus broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a strong buy rating.

Brokers have set a twelve-month consensus price objective of $7.00 for the company, according to Zacks. Zacks has also given Oculus Innovative Sciences an industry rank of 106 out of 265 based on the ratings given to its competitors.

Separately, Maxim Group reiterated a “buy” rating and issued a $3.00 target price on shares of Oculus Innovative Sciences in a report on Friday, June 17th.

Shares of Oculus Innovative Sciences (NASDAQ:OCLS) opened at 4.20 on Monday. The company’s market cap is $17.64 million. The company has a 50-day moving average price of $4.21 and a 200-day moving average price of $4.49. Oculus Innovative Sciences has a 1-year low of $3.57 and a 1-year high of $7.15.

Oculus Innovative Sciences (NASDAQ:OCLS) last issued its earnings results on Thursday, July 28th. The company reported ($0.61) earnings per share for the quarter. Oculus Innovative Sciences had a negative return on equity of 108.93% and a negative net margin of 68.29%. Equities research analysts expect that Oculus Innovative Sciences will post ($2.04) earnings per share for the current fiscal year.

About Oculus Innovative Sciences

Oculus Innovative Sciences, Inc is a specialty pharmaceutical company, which focuses on identifying, developing and commercializing therapies to manage the lives of patients with dermatologic diseases or conditions. The Company’s products treat certain topical skin diseases, including acne, atopic dermatitis, scarring, infections, itch, pain and inflammatory responses.

5 Day Chart for NASDAQ:OCLS

Get a free copy of the Zacks research report on Oculus Innovative Sciences (OCLS)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Oculus Innovative Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oculus Innovative Sciences Inc. and related companies with's FREE daily email newsletter.

Leave a Reply

© 2006-2016 Mideast Time.